Living on the Margins: Women Writers on Breast Cancer

(5)
Living on the Margins: Women Writers on Breast Cancer image
ISBN-10:

0892552700

ISBN-13:

9780892552702

Author(s): Raz, Hilda
Edition: First Edition
Released: Oct 01, 2001
Publisher: Persea
Format: Paperback, 304 pages
Related ISBN: 9780892552443

Description:

In this powerful anthology of personal narratives, essays, shaped journals, and poems, eighteen women writers share their experiences with breast cancerfrom diagnosis and treatment, to aspects of marriage, motherhood, friendship, sexuality, work, and recurrence. Lucille Clifton, Carol Dine, Elaine Greene, Marilyn Hacker, Judith Hall, Safiya Henderson-Holmes, Annette Williams Jaffee, Maxine Kumin, Amy Ling, Claudia MonPere McIsaac, Carole Simmons Oles, Alicia Ostriker, Pamela Post, Hilda Raz, Mimi Schwartz, Eve Kosofsky Sedgwick, Sandra Spanier (on Kay Boyle), and Janet Sternberg. Includes an interview with Dr. Susan Love.

Best prices to buy, sell, or rent ISBN 9780892552702




Frequently Asked Questions about Living on the Margins: Women Writers on Breast Cancer

You can buy the Living on the Margins: Women Writers on Breast Cancer book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $5.34 on Amazon and is available from 12 sellers at the moment.

If you’re interested in selling back the Living on the Margins: Women Writers on Breast Cancer book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Living on the Margins: Women Writers on Breast Cancer book, the best buyback offer comes from and is $ for the book in good condition.

The Living on the Margins: Women Writers on Breast Cancer book is in very low demand now as the rank for the book is 6,817,574 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.